Tech24 Deals Web Search

Search results

1. Results from the Tech24 Deals Content Network

2. Orlistat - Wikipedia

   en.wikipedia.org/wiki/Orlistat

   Orlistat, sold under the brand name Xenical among others, is a medication used to treat obesity. Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet.

3. Walmart says users of weight-loss drugs are buying less food

   www.aol.com/news/walmart-says-weight-loss-drug...

   Walmart says people who get weight loss drugs like Wegovy at its pharmacies are buying a bit less food at its stores. Walmart's U.S. CEO, John Furner, told Bloomberg News that the company is ...

4. Weight loss-aiding drugs Ozempic and Wegovy are ... - AOL

   www.aol.com/finance/weight-loss-aiding-drugs...

   The success of drugs like Ozempic and Wegovy in treating weight loss could be driving Americans to spend less money on food, a top Walmart executive has said. “We definitely do see a slight ...

5. Pepsi’s CEO is keeping an eye on weight-loss drugs, but ...

   www.aol.com/finance/pepsi-ceo-keeping-eye-weight...

   Pepsi’s CEO is keeping an eye on weight-loss drugs, but shakes off fears voiced by Walmart that they could hurt the bottom line Christiaan Hetzner October 11, 2023 at 7:53 AM

6. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   e. Orlistat (Xenical), the most commonly used medication to treat obesity and sibutramine (Meridia), a medication that was withdrawn due to cardiovascular side effects. Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of ...

7. Sibutramine - Wikipedia

   en.wikipedia.org/wiki/Sibutramine

   Sibutramine is a serotonin–norepinephrine reuptake inhibitor (SNRI) that, in humans, reduces the reuptake of norepinephrine (by ~73%), serotonin (by ~54%), and dopamine (by ~16%), [ 22] thereby increasing the levels of these substances in synaptic clefts and helping enhance satiety; the serotonergic action, in particular, is thought to ...